Results 141 to 150 of about 2,176,861 (324)

Real‐World Effectiveness and Safety of Topical Ruxolitinib in Adolescents With Vitiligo: A 52‐Week Retrospective Study

open access: yesJEADV Clinical Practice, EarlyView.
Topical ruxolitinib 1.5% cream was assessed in 39 adolescents with non‐segmental vitiligo. Median T‐VASI fell at week 24 (n = 34) and week 52 (n = 18), with repigmentation most pronounced on the face: 55.6% reached F‐VASI50 at week 52. Few adverse events were recorded, all mild application‐site reactions in 4 of 39 patients.
L. Coronella   +3 more
wiley   +1 more source

Chronic Pruritic Papular Eruption in an Elderly Man

open access: yes
JEADV Clinical Practice, EarlyView.
Filipe Monteiro   +6 more
wiley   +1 more source

Subcorneal Pustular Dermatosis, a Systematic Review and Pooled Analysis of a Rare and Underdiagnosed Disease

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Subcorneal pustular dermatosis (SPD), or Sneddon–Wilkinson disease, is a rare, relapsing pustular skin condition of unknown cause, characterised by subcorneal pustules. Objectives To summarise the demographic, clinical, histopathological, management and disease course of SPD.
Mason H. Crossman   +5 more
wiley   +1 more source

Progressive Improvements with Repeated High-Concentration Capsaicin Patch: Real-World Data from the Retrospective CASPAR German Pain e-Registry Study in Postherpetic Neuralgia

open access: yesDermatology and Therapy
Introduction Postherpetic neuralgia (PHN) is a chronic neuropathic pain condition that disproportionally affects older adults. First-line oral treatments often yield suboptimal relief and may cause systemic side effects and drug–drug interactions ...
Sonja Ständer   +8 more
doaj   +1 more source

IBAT INHIBITION IN CHRONIC CHOLESTATIC LIVER DISEASES: FROM PRURITUS CONTROL TO POTENTIAL DISEASE MODIFICATION [PDF]

open access: bronze
Dagmara Laufer   +5 more
openalex   +1 more source

Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis

open access: yesDermatology and Therapy
Introduction In pooled LIBERTY-PN PRIME/PRIME2 trials on prurigo nodularis (PN), at week 24, the stringent composite endpoint of a ≥ 4-point reduction from baseline in Worst Itch Numeric Rating Scale (WI-NRS) score combined with an Investigator’s Global ...
Sonja Ständer   +8 more
doaj   +1 more source

Resting-state electroencephalographic characteristics in patients with atopic dermatitis accompanied by chronic pruritus [PDF]

open access: gold
Dan Sun   +8 more
openalex   +1 more source

Real World Use of the IL‐36 Receptor Antagonist Spesolimab: A Systematic Review and Analysis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Spesolimab, an interleukin‐36 receptor antagonist, is approved for the treatment and prevention of generalised pustular psoriasis (GPP) flares. Its use has increasingly been reported in real‐world settings for both GPP and other inflammatory dermatoses.
Sophia A. Mense   +4 more
wiley   +1 more source

Pink Polypoid Papulo‐Vesicles on Labia Majora

open access: yes
JEADV Clinical Practice, EarlyView.
Maria Chiara Mercuri   +3 more
wiley   +1 more source

Dominant ELOVL1‐Related Ichthyotic Keratoderma (IKSHD) in an Adult: Preserved Cognition With Functional Autonomy and Epilepsy

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Ichthyotic keratoderma with spasticity, hypomyelination and dysmorphic features (IKSHD; OMIM #618527) is an ultra‐rare neuroichthyosis caused by dominant variants in ELOVL1, the elongase of very‐long‐chain fatty acids required for both the epidermal permeability barrier and central nervous system myelin.
Roxana Pirker   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy